PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Goncalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rua Waldemar Falcão, 121, Candeal, Salvador, Bahia, 40296-710, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Salvador, Brazil.\', \'Center for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil.\', \'Graduate Program in Medicine and Health, Faculty of Medicine, Federal University of Bahia, Salvador, Brazil.\', \'Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.\', \'National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Rio de Janeiro, Brazil.\', \'COVID-19 Virus Network, Ministry of Science and Technology, and Innovation, Rio de Janeiro, Brazil.\', \'Goncalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rua Waldemar Falcão, 121, Candeal, Salvador, Bahia, 40296-710, Brazil. bruno.solano@fiocruz.br.\', \'D\'Or Institute for Research and Education (IDOR), Salvador, Brazil. bruno.solano@fiocruz.br.\', \'Center for Biotechnology and Cell Therapy, São Rafael Hospital, Salvador, Brazil. bruno.solano@fiocruz.br.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13287-021-02502-7
?:hasPublicationType
?:journal
  • Stem cell research & therapy
is ?:pmid of
?:pmid
?:pmid
  • 34315546
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all